Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Repairing complex abdominal aortic aneurysms with specialized stent grafts

Official title: Clinical Outcomes and Quality of Life Measures in Patients Treated for Complex Abdominal Aortic Aneurysms With Fenestrated Stent Grafts

Run by Baylor College of Medicine · NCT01937949 · Data updated 2026-11-12

This study is testing if special stent grafts can safely and effectively repair complex abdominal aortic aneurysms in patients with specific types of these aneurysms.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorBaylor College of Medicine
Academic / other
Locations2 sites (Rochester, Minnesota and 1 other locations)
StatusRecruiting
StartedAugust 2013
Main results expectedMarch 2025
Study endsMay 2030
Registry record updatedJanuary 20, 2026
Trial IDNCT01937949 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with juxtarenal, suprarenal, or type IV thoracoabdominal aortic aneurysms that are at least 5.0 cm in diameter or have shown significant growth.

Probably not a fit

Patients under 18, those with a life expectancy of less than 2 years, or those unable to comply with follow-up may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the clinical outcomes and quality of life for patients undergoing endovascular repair of complex abdominal aortic aneurysms using custom-made Cook Zenith® Fenestrated AAA Endovascular Grafts. It aims to gather preliminary safety and efficacy data that could inform future studies and product development. The focus is on patients with juxtarenal, suprarenal, and type IV thoracoabdominal aortic aneurysms that meet specific size and growth criteria.

Why it matters

Potential benefit: If successful, this approach could significantly improve treatment options and outcomes for patients with complex aortic aneurysms.

How similar studies have gone: Other studies using similar endovascular approaches have shown promising results, indicating potential for success in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
General Inclusion Criteria

* A patient may be included in the study if the patient has at least one of the following and is appropriate for treatment with a custom-made Zenith® Fenestrated AAA Endovascular Graft:
* Juxtarenal, suprarenal or type IV thoracoabdominal aortic aneurysm with a diameter ≥ 5.0 cm or 2 times the normal aortic diameter
* Aneurysm with a history of growth ≥ 0.5 cm per year
* Saccular aneurysms deemed at significant risk for rupture based upon physician interpretation.

General Exclusion Criteria

* Less than 18 years of age
* Unwilling to comply with the follow-up schedule
* Inability or refusal to give informed consent by the patient or a legally authorized representative
* Pregnant or breastfeeding
* Life expectancy \< 2-years
* Additional medical restrictions as specified in the Clinical Investigation Plan
* Additional anatomical restrictions as specified in the Clinical Investigation Plan

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.